Evaluation of plasma anti-CS3 and anti-LTB IgG avidity among Zambian children vaccinated with ETVAX
Cynthia Mubanga, Mutale Mubanga, Obvious Nchimunya Chilyabanyama, Masauso Moses Phiri, Caroline Cleopatra Chisenga, Richard Helmuth Glashoff, Roma Chilengi
This study evaluates anti-CS3 and anti-LTB IgG avidity in Zambian children vaccinated with ETVAX, finding that avidity changes little over time but shows inter-individual variation.
PLoS ONE · May 15, 2026Peer-reviewedImmunology